Spain (ES)

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial (2023) Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, et al. Journal article The high energy X-ray probe (HEX-P): a new window into neutron star accretion (2023) Ludlam RM, Malacaria C, Sokolova-Lapa E, Fuerst F, Pradhan P, Shaw AW, Pottschmidt K, et al. Journal article Programming of neural progenitors of the adult subependymal zone towards a glutamatergic neuron lineage by neurogenin 2 (2023) Péron S, Miyakoshi LM, Brill MS, Manzano-Franco D, Serrano-López J, Fan W, Marichal N, et al. Journal article Fiber alignment in 3D collagen networks as a biophysical marker for cell contractility (2023) Böhringer D, Bauer A, Moravec I, Bischof L, Kah DTE, Mark C, Grundy TJ, et al. Journal article Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (2023) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article Operando methods: A new era of electrochemistry (2023) Yang Y, Feijóo J, Briega-Martos V, Li Q, Krumov M, Merkens S, De Salvo G, et al. Journal article, Review article Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study (2023) Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. Journal article Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension (2023) D'Agostino MA, Carron P, Gaillez C, Conaghan PG, Naredo E, López-Rdz A, Šenolt L, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article Addressing health inequity during the COVID-19 pandemic through primary health care and public health collaboration: a multiple case study analysis in eight high-income countries (2023) Vanden Bossche D, Zhao QJ, Ares-Blanco S, Peña MPA, Decat P, Kondo N, Kroneman M, et al. Journal article